<DOC>
	<DOCNO>NCT00928525</DOCNO>
	<brief_summary>The purpose study determine whether Imatinib Mesylate active disease - Desmoid Tumor Chondrosarcoma - express receptor platelet-derived growth factor ( PDGF ) isoform alpha beta</brief_summary>
	<brief_title>Imatinib Patients With Desmoid Tumor Chondrosarcoma</brief_title>
	<detailed_description />
	<mesh_term>Chondrosarcoma</mesh_term>
	<mesh_term>Fibromatosis , Aggressive</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Histological diagnosis DT CDS . Biomolecular immunohistochemical evidence Imatinib mesylate target ( KIT , PDGFRα PDGFRβ activation and/or presence PDGFα PDGFβ ) Measurable evaluable disease Surgical resection local disease unfeasible radically ( unaccepted patient , amenable become less demolitive , easy , likely feasible , cytoreduction ) and/or metastatic disease . ECOG Performance status 0 , 1 , 2 3 Adequate bone marrow , liver renal function Female patient childbearing potential must negative pregnancy test . Male female patient reproductive potential must agree employ effective method birth control throughout study . Written , voluntary , informed consent . Previous treatment investigational investigational agent within 28 day first day study drug dose Other primary malignancy &lt; 5 year clinically assess diseasefree interval , except basal cell skin cancer cervical carcinoma situ . Grade III/IV cardiac problem define New York Heart Association Criteria Severe and/or uncontrolled medical disease ( i.e. , uncontrolled diabetes , chronic renal disease , active uncontrolled infection ) Known brain metastasis . Known chronic liver disease ( i.e. , chronic active hepatitis , cirrhosis ) . Known diagnosis human immunodeficiency virus ( HIV ) infection . Previous radiotherapy &gt; /=25 % bone marrow within previous 2 month target lesion . Major surgery within 2 week prior study entry . Expected noncompliance medical regimen ( e.g . psychiatric disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PDGFr alpha</keyword>
	<keyword>PDGFr beta</keyword>
	<keyword>KIT</keyword>
</DOC>